Updates for 2022
Share your knowledge with orthopaedic surgeons from around the world at the 2022 OTA Annual Meeting, October 12-15, 2022 in Tampa, Florida

Scientific Paper submissions - Now Open
Deadline: February 2, 2022 
11:59 PM CST
For site login, click here.

Symposia, breakouts, and technical tricks and tips submissions
Deadline: March 2, 2022 11:59 PM CST
The site will open February 3, 2022.

The Annual Meeting Program Committee has made additional changes to the submission process to make author submissions easier. See highlights below:

1) Author's names and institutions are no longer included in the word count

2) The maximum abstract length is 400 words (no longer 2600 characters)

3) Group authorship names are now an easy option

4) The presenting author and corresponding author will receive notifications of abstract status

 

SUBMISSION FORM

Jump To

SUBMISSION CATEGORIES

Paper: Paper presentations are six minutes in length. There is not a separate submission form for posters. The OTA Program Committee will determine the most effective presentation method, either paper or poster.

Breakout: One main topic with a moderator and 3 to 4 faculty. Open to questions from the audience. This includes case presentations. Concurrent breakout sessions are held throughout the meeting — 60 min in length. 

Main Symposium: One main topic with a moderator and 3 to 5 faculty. Leave room for discussion and questions at the end of the session. This is held in the general session room with no conflicting sessions — 90 min in length. 

Technical Tricks and Innovation: This category showcases innovative techniques and technologies and consists of case reports showing unique solutions to difficult problems.

The abstract shows a description of preliminary findings using new technology. This category is not designed to serve as an advertisement for a particular commercial product, so please avoid the appearance of commercial bias. You cannot submit your abstract to both this category and the paper category. You must choose one category.

Presentation will be a single slide (similar to a poster) displayed digitally throughout the course of the meeting.

IMPORTANT NOTE: Complete author disclosure is required for all submissions. Disclosures must be dated October 13, 2021, or later. Any disclosures made before this date will not be valid. There will be a 7-day author disclosure grace period from the close of abstract submissions. If an abstract does not have complete author disclosure by February 9, 2022, the abstract will not be reviewed by the OTA Program Committee. This includes breakout, main symposium, and technical tricks and innovation submissions. The name of the author must match exactly what is in the AAOS database to integrate with the author’s disclosure.

GENERAL GUIDELINES FOR PAPER ABSTRACTS

  • Research that has been published or is scheduled to be published before OTA should not be submitted for consideration.
  • Paper and Posters accepted at a previous OTA meeting are not eligible for submission.
  •  The OTA program committee will determine the most effective presentation method, either paper or poster. Abstracts may also be chosen for paper or poster presentation at the Basic Science Focus Forum or International Orthopaedic Trauma Care Forum.
  • Faculty participation is limited to 3 Annual Meeting breakout sessions per person. This does not include pre-meeting events.
  •  It is the responsibility of the submitting author to communicate all presentation information to the presenting author.
  • There is no numerical limit on the number of abstracts an author may submit.  However, an author may present only one paper per session; various co-authors must present any additionally accepted abstracts.
  • Financial disclosures are mandatory for the Presenting Author and Corresponding Author listed on abstracts. No abstract (whether podium or poster) may be presented without financial disclosure of the Presenting Author and Corresponding Author
  • Text must be blinded (no references to author, institutions, or country within the body or title of the abstract. Non-blinded abstracts will not be considered.

GENERAL GUIDELINES FOR BREAKOUTS AND SYMPOSIA 

  • Faculty participation is limited to 3 Annual Meeting breakout sessions per person. This does not include pre-meeting events.
  • It is the responsibility of the submitting author to communicate all presentation information to the faculty.
  • Financial disclosures are mandatory for each faculty on a breakout or symposium. A submission that does not have full faculty disclosure will not be considered by the Program Committee.  
  • Breakout submissions are limited to 3 submissions per user. 
  • Symposia submissions are limited to 3 submissions per user. 
  • Confirm participation with all faculty prior to submission. 

REQUIRED FORMATTING OF ABSTRACTS

  • Abstract character count cannot exceed 400 words. Title, Purpose, Methods, Results, and Conclusion, all count toward the 400 words. Adding an image will reduce the character count by 125 words. 
  • Graphs and Images: You may upload one associated file or graphic that is no larger than 5mb. This will affect the word count by 125 words. The graphics size will be reduced to 3 x 3 during the conversion process. For best results, size your image to 3 inches x 3 inches (76 mm x 76 mm). 
  • Abstracts must contain Purpose (hypothesis), Method, Result, and Conclusion.
  • Define any abbreviations the first time they are used.
  • It is required that all terminology, description, and clarification of fractures and injuries be according to the OTA/AO Fracture and Dislocation Compendium. The Fracture Compendium is published in the Journal of Orthopaedic Trauma; Vol 32, Supplement 1, January 2018:  Fracture Compendium.  

AUTHORS AND FINANCIAL DISCLOSURES 

The AAOS disclosure system will be used to manage author and presenter disclosures for OTA. EACH author, including the presenting author, is required to disclose in the AAOS database.

  • If a co-author does not have a record in the AAOS database, they will receive an email containing a link where they can create a record in the AAOS database.
     
  • When submitting your authors, please search each co-author by the last name (required), first name, and email address (optional). The name of the author must match exactly what is in the AAOS database to integrate with the author’s disclosure. Please use the directional arrows (up/down) to be sure co-authors/presenter is in the correct order. Click the edit button to change who the presenting author will be listed as.
     
  • There will be a 7-day author disclosure grace period from the close of abstract submissions. All disclosures for the meeting must be made on or after -October 26, 2021. Any disclosures made prior to this date will not be valid. If an abstract does not have complete author disclosure by February 9, 2022 the abstract will not be reviewed by the OTA Program Committee. 
     
  • You must have the correct full name for every co-author on the abstract. The abstract system will search for each co-author by last name in the AAOS database. The name of the author must match exactly what is in the AAOS database in order to integrate with the author's disclosure. Once you have entered all the co-authors and submitted your abstract, you can click “view summary” to view each co-author’s disclosure status.

BASIC SCIENCE ABSTRACTS

Authors are frequently unsure if their study should be submitted in the basic science or the clinical section.  If the study involves non-living human it most likely should be submitted under "Basic Science". This includes biomechanical studies on cadaveric bones or surrogates, studies involving animals, anatomic cadaveric studies, as well as other traditional basic science topics.  Meta-analyses, economic studies, and traditional clinical studies should continue to be submitted in the clinical sections. The program committee reserves the right to move the submission to the section deemed most appropriate.
 

LARGE DATABASE STUDIES

There has been a recent increase in submissions of so-called "large database" research. The program committee suggests that authors consider recent recommendations for high-quality studies in the domain [1]. Two particularly relevant suggestions from the editorial include: "[Studies Should] correlate less-common adverse events with modifiable and previously unidentified risk factors, identify adjustable provider - or hospital-level variables associated with readmissions or complication, and compare resource utilization for common interventions across diverse geographic regions or practice settings. [Additionally, studies should] either presented genuinely counterintuitive descriptive finding or provide a specific suggestion to improve clinical care, practice management or public policy.” Large database studies that do not follow these guidelines are unlikely to be accepted.

1. 
Editorial: large database studies - what they can do, what they cannot do, and which ones we will publish, Grauer JN, Leopold SS, Clin Orthop Relat Res. 2015 May; 473(5):1537-9.

FINALIZING YOUR SUBMISSION

Once you have uploaded your abstract you should preview your abstract on the final page. If your abstract is complete, including all authors, you will be able to submit your abstract. Once all requirements are met, the presenting and corresponding author will receive a confirmation email.

An abstract can be edited at any time up until the submission deadline. The best way to ensure your abstract was submitted and is complete is to check the status. If you return to the abstract submission site, you will see your submitted abstract(s), abstract tracking/ID number(s), and status. If an abstract is incomplete, click the edit page.

MEETING ATTENDANCE

Each presenter is asked to return an electronically signed response stating that s/he will present the accepted paper.

  • Those who sign but are unable to attend are asked to find a co-author to attend and present and alert the OTA office of the change.
  • If you are unable to attend and find a replacement you must notify the OTA Office. Those that fail to notify the OTA office and are a no-show will not be allowed to submit an abstract or present at the meeting for the next two years
  • Urgent issues will be handled at the discretion of the OTA Program Committee Chair.

IMPORTANT DATES

February 2, 2022 11:59 PM CST

Abstract Submission Closes

February 9, 2022

7-Day Author Disclosure Grace Period Ends

Late-May 2022

Submitters will be notified

June 2021

Annual Meeting Registration Opens

 

Abstract Submission FAQ

Back to Top